Exact Mass: 622.2625282
Exact Mass Matches: 622.2625282
Found 83 metabolites which its exact mass value is equals to given mass value 622.2625282
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Allosamidin
D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
O-Methylsomniferine
C37H38N2O7 (622.2678877999999)
O-Methylsomniferine is an alkaloid from Papaver somniferum (opium poppy). Alkaloid from Papaver somniferum (opium poppy)
Allosamidin
Campto
C33H38N4O6.HCl (622.2557983999999)
Irinotecan hydrochloride (anhydrous) is a hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of its trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active. It has a role as an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent, an apoptosis inducer and a prodrug. It contains an irinotecan(1+). Irinotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent. A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. See also: Irinotecan (has active moiety). D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer[1].
O-Methylsomniferine
C37H38N2O7 (622.2678877999999)
1alpha,2alpha,6beta-triacetoxy-4beta-hydroxy-9beta-(beta-)furancarboxy-15-[(alpha-methyl)butyroyloxy]-beta-dihydroagarofuran
Campto
Irinotecan hydrochloride (anhydrous) is a hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of its trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active. It has a role as an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent, an apoptosis inducer and a prodrug. It contains an irinotecan(1+). Irinotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent. A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. See also: Irinotecan (has active moiety). D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer[1].
Met Met Arg Trp
Met Met Trp Arg
Met Arg Met Trp
Met Arg Trp Met
Met Thr Trp Trp
C31H38N6O6S (622.2573408000001)
Met Trp Met Arg
Met Trp Arg Met
Met Trp Thr Trp
C31H38N6O6S (622.2573408000001)
Met Trp Trp Thr
C31H38N6O6S (622.2573408000001)
Arg Met Met Trp
Arg Met Trp Met
Arg Trp Met Met
Thr Met Trp Trp
C31H38N6O6S (622.2573408000001)
Thr Trp Met Trp
C31H38N6O6S (622.2573408000001)
Thr Trp Trp Met
C31H38N6O6S (622.2573408000001)
Trp Met Met Arg
Trp Met Arg Met
Trp Met Thr Trp
C31H38N6O6S (622.2573408000001)
Trp Met Trp Thr
C31H38N6O6S (622.2573408000001)
Trp Arg Met Met
Trp Thr Met Trp
C31H38N6O6S (622.2573408000001)
Trp Thr Trp Met
C31H38N6O6S (622.2573408000001)
Trp Trp Met Thr
C31H38N6O6S (622.2573408000001)
Trp Trp Thr Met
C31H38N6O6S (622.2573408000001)
2,3,7,8,12,13,17,18-OCTAETHYL-21H,23H-PORPHINE MANGANESE(III) CHLORIDE
6,6,7,12-Tetramethoxy-2-methyl-1,2-didehydroberbaman-5-ol
C37H38N2O7 (622.2678877999999)
9,20,21,25-Tetramethoxy-15-methyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-1(30),3(36),4,6(35),8,10,12(34),18(33),19,21,24,26,31-tridecaen-19-ol
C37H38N2O7 (622.2678877999999)
2-[(2R,4aR,12aR)-8-[[(2-fluoroanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
Hexafluoroisopropyl 3beta-trifluoroacetoxy-5beta-cholan-24-oate
C29H39F9O4 (622.2704481999999)
Hexafluoroisopropyl 3beta-trifluoroacetoxy-5alpha-cholan-24-oate
C29H39F9O4 (622.2704481999999)
n-[(2r,3r,4s,5s,6s)-2-{[(3as,4s,5s,6r,6ar)-4-hydroxy-6-(hydroxymethyl)-2-(methylimino)-hexahydrocyclopenta[d][1,3]oxazol-5-yl]oxy}-5-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(methoxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
n-[(2r,3s,4r,5s,6r)-2-{[(3ar,4r,5r,6r,6as)-4-hydroxy-6-(hydroxymethyl)-2-(methylimino)-hexahydrocyclopenta[d][1,3]oxazol-5-yl]oxy}-5-{[(2s,3r,4r,5s,6s)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(methoxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
(2r,3r,4r,5r,6r)-6-{[(2e)-3,7-dimethyl-6-oxoocta-2,7-dien-1-yl]oxy}-5-hydroxy-2-(hydroxymethyl)-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(1s,2r,3s,4r,5s,7s,8r,9s,10s,12z,14s,17r)-2,7,9,10-tetrakis(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl propanoate
n-[5-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(methoxymethyl)oxan-2-yl}oxy)-4-hydroxy-2-{[4-hydroxy-6-(hydroxymethyl)-2-(methylimino)-hexahydrocyclopenta[d][1,3]oxazol-5-yl]oxy}-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
8-{[1-({4-[5-(hydroxymethyl)-2-methoxyphenoxy]phenyl}methyl)-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-yl]oxy}-6-methoxy-2-methylisoquinolin-2-ium-7-olate
C37H38N2O7 (622.2678877999999)
methyl 2-(1-hydroxy-5-{[2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl)prop-2-enoate
8-{[(1s)-1-({4-[5-(hydroxymethyl)-2-methoxyphenoxy]phenyl}methyl)-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-yl]oxy}-6-methoxy-2-methylisoquinolin-2-ium-7-olate
C37H38N2O7 (622.2678877999999)
2,7,9,10-tetrakis(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl propanoate
n-[(2s,3r,4s,5s,6r)-2-{[(2r,3s,4s,5r,6r)-6-{[(3ar,4r,5r,6s,6as)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-3ah,4h,5h,6h,6ah-cyclopenta[d][1,3]oxazol-5-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
n-{2-[(6-{[2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-3ah,4h,5h,6h,6ah-cyclopenta[d][1,3]oxazol-5-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl}ethanimidic acid
2-{[2-hydroxy-3-({2-hydroxy-2-methyl-3-[(2-methylbut-2-enoyl)oxy]butanoyl}oxy)-2-methylbutanoyl]oxy}-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propyl 2-methylbut-2-enoate
(3s,14s,22r)-27-hydroxy-16,26-dimethoxy-4,21-dimethyl-12,29,37-trioxa-4,21-diazaoctacyclo[28.2.2.1⁷,¹¹.1¹⁰,¹⁴.1¹⁴,¹⁸.1²⁴,²⁸.0³,⁸.0²²,³⁶]octatriaconta-1(32),7(38),8,10,16,18(36),24,26,28(35),30,33-undecaen-15-one
C37H38N2O7 (622.2678877999999)
(1s,17s)-23,28-dimethoxy-18,33-dimethyl-7,10,12,26-tetraoxa-18,33-diazaoctacyclo[25.6.2.2³,⁶.1⁸,¹⁵.1¹⁷,²¹.0⁹,¹³.0³⁰,³⁴.0²⁵,³⁶]nonatriaconta-3,5,8(37),9(13),14,21(36),22,24,27(35),28,30(34),38-dodecaen-24-ol
C37H38N2O7 (622.2678877999999)
methyl 2-[(1s,2s,4ar,5r,8as)-1-hydroxy-5-{[2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl]prop-2-enoate
(25s)-4,5,20,31-tetramethoxy-26-methyl-2,18-dioxa-11,26-diazaheptacyclo[23.6.2.2¹⁴,¹⁷.1¹⁹,²³.0³,⁸.0⁷,¹².0²⁹,³³]hexatriaconta-1(32),3,5,7,11,14,16,19(34),20,22,29(33),30,35-tridecaen-30-ol
C37H38N2O7 (622.2678877999999)
n-[(2s,3r,4s,5s,6r)-2-{[(2r,3s,4s,5r,6r)-6-{[2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-3ah,4h,5h,6h,6ah-cyclopenta[d][1,3]oxazol-5-yl]oxy}-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
(1s,2s,3r,4r,8s,9r,10r,13r,14s,15r,16r)-3,14,15,16-tetrakis(acetyloxy)-9-hydroxy-9,14-dimethyl-6-oxo-4-(prop-1-en-2-yl)-5-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-2-yl propanoate
(1s,2r)-2-{[(2r,3s)-2-hydroxy-3-{[(2r,3s)-2-hydroxy-2-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}butanoyl]oxy}-2-methylbutanoyl]oxy}-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propyl (2z)-2-methylbut-2-enoate
methyl 2-[(1s,2s,4ar,5r,8as)-1-hydroxy-5-{[(2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl]prop-2-enoate
3,14,15,16-tetrakis(acetyloxy)-9-hydroxy-9,14-dimethyl-6-oxo-4-(prop-1-en-2-yl)-5-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-2-yl propanoate
23,28-dimethoxy-18,33-dimethyl-7,10,12,26-tetraoxa-18,33-diazaoctacyclo[25.6.2.2³,⁶.1⁸,¹⁵.1¹⁷,²¹.0⁹,¹³.0³⁰,³⁴.0²⁵,³⁶]nonatriaconta-3,5,8(37),9(13),14,21(36),22,24,27(35),28,30(34),38-dodecaen-24-ol
C37H38N2O7 (622.2678877999999)